CELEX: 62019TA0264
Language: en
Date: 2020-10-05 00:00:00
Title: Case T-264/19: Judgment of the General Court of 5 October 2020 — nanoPET Pharma v EUIPO — Miltenyi Biotec (viscover) (EU trade mark — Invalidity proceedings — EU figurative mark viscover — Absence of bad faith — Article 52(1)(b) of Regulation (EC) No 207/2009 (now Article 59(1)(b) of Regulation (EU) No 2017/1001) — Article 53(2)(c) of Regulation No 207/2009 (now Article 60(2)(c) of Regulation 2017/1001))

30.11.2020   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 414/35
            
         
      Judgment of the General Court of 5 October 2020 — nanoPET Pharma v EUIPO — Miltenyi Biotec (viscover)
      (Case T-264/19) (1)
      
      (EU trade mark - Invalidity proceedings - EU figurative mark viscover - Absence of bad faith - Article 52(1)(b) of Regulation (EC) No 207/2009 (now Article 59(1)(b) of Regulation (EU) No 2017/1001) - Article 53(2)(c) of Regulation No 207/2009 (now Article 60(2)(c) of Regulation 2017/1001))
      (2020/C 414/55)
      Language of the case: German
      
         Parties
      
      
         Applicant: nanoPET Pharma GmbH (Berlin, Germany) (represented by: C. Onken and A. Schulz, lawyers)
      
         Defendant: European Union Intellectual Property Office (represented by: D. Hanf, Agent)
      
         Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Miltenyi Biotec BV & Co. KG, formerly Miltenyi Biotec GmbH (Bergisch Gladbach, Germany) (represented by: M. Schork, lawyer)
      
         Re:
      
      Action brought against the decision of the Fifth Board of Appeal of EUIPO of 17 January 2019 (Case R 1288/2017-5), concerning invalidity proceedings between nanoPET Pharma and Miltenyi Biotec.
      
         Operative part of the judgment
      
      The Court:
      
                  1.
               
               
                  Dismisses the action;
               
            
                  2.
               
               
                  Orders nanoPET Pharma GmbH to pay the costs.
               
            
         (1)  OJ C 206, 17.6.2019.